Customer Discovery in Early-Stage Life Sciences

Most life science companies don't fail because the science was wrong. They fail because no one validated the problem, the customer, or the market before spending years and millions building toward them. Join Cornell's Center for Technology Licensing (CTL) on Thursday, June 18, at noon ET for Customer Discovery in Early-Stage Life Sciences, a virtual conversation about what it actually takes to test whether the problem is real, the customer exists, and the market is worth pursuing. During this session, attendees will learn about: How investors evaluate whether a life science team has done meaningful customer discoveryWhat product development looks like when the customer is a surgeon, a hospital system, or a payerHow faculty inventors balance lab progress with the messy work of market validationCommon mistakes early-stage founders make before their first pitchThe panel brings together Audrey Beckman (Boomerang Ventures), Dave Saunders (AiM Medical Robotics), and Dr. Amir Goldan (Weill Cornell Medicine), moderated by Donna Rounds, Ph.D., from CTL at Weill Cornell.